Stay updated on Nivolumab and Trabectedin in Soft Tissue Sarcomas Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Trabectedin in Soft Tissue Sarcomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Trabectedin in Soft Tissue Sarcomas Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The NiTraSarc study page now shows a 403 Forbidden error with a minimal header and a Home link; the detailed study content is no longer visible, leaving an error screen as the primary content.
    Difference
    19%
    Check dated 2026-09-23T01:02:28.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision: v3.7.0 is now shown on the page, replacing v3.6.6. This indicates a software/content update to the Study Details page without altering the underlying study data.
    Difference
    0.1%
    Check dated 2026-09-16T00:28:42.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    Footer revision label updated from Revision: v3.6.5 to Revision: v3.6.6, representing a minor page update. It does not indicate changes to the study content or data.
    Difference
    0.1%
    Check dated 2026-09-01T20:32:48.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    An entry '2017 ( U.S. NIH Grant/Contract )' was added to the study's identifiers/funding area, appearing alongside the GISG and EudraCT numbers. This enriches the record with NIH funding attribution for that year.
    Difference
    0.1%
    Check dated 2026-08-25T22:11:32.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Revision updated from v3.6.4 to v3.6.5, indicating a platform version update on the page.
    Difference
    0.0%
    Check dated 2026-08-11T21:43:05.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    The page shows a new revision label (v3.6.4) replacing the previous v3.6.3, indicating a software update to the page. The change does not modify study content or essential outcomes.
    Difference
    0.0%
    Check dated 2026-07-21T13:15:15.000Z thumbnail image

Stay in the know with updates to Nivolumab and Trabectedin in Soft Tissue Sarcomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Trabectedin in Soft Tissue Sarcomas Clinical Trial page.